Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats

Rossella Rota, Carlo Chiavaroli, Ricardo P. Garay, Patrick Hannaert

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Calcium dobesilate stabilizes blood-retinal barrier in patients with diabetic retinopathy and possesses antioxidant properties in the retinas of rats with streptozotocin-induced diabetes, exposed ex vivo to ischemia-reperfusion. Here we investigated the action of calcium dobesilate on retinal albumin leakage in streptozotocin-diabetic rats, together with relevant in vivo retinal antioxidant and permeability markers, i.e., carboxymethyl-lysine-advanced glycation end product (CML-AGE) formation and vascular endothelial cell growth factor (VEGF) overexpression. Twenty days after streptozotocin administration, diabetic rats were treated for 10 days with calcium dobesilate (100 mg/kg/day per os) or vehicle. Retinal albumin leakage, CML-AGE formation, and VEGF overexpression were evaluated by immunohistochemistry of frozen eye sections. Diabetic rats exhibited dramatic increases in: (i) retinal albumin leakage (31% of positive vessels vs. 0.2% in nondiabetic rats, P-4). Calcium dobesilate significantly reduced: (i) retinal albumin leakage (by 70%, P

Original languageEnglish
Pages (from-to)217-224
Number of pages8
JournalEuropean Journal of Pharmacology
Volume495
Issue number2-3
DOIs
Publication statusPublished - Jul 14 2004

Fingerprint

Calcium Dobesilate
Streptozocin
Albumins
Antioxidants
Advanced Glycosylation End Products
Vascular Endothelial Growth Factor A
Blood-Retinal Barrier
Experimental Diabetes Mellitus
Frozen Sections
Diabetic Retinopathy
Reperfusion
Retina
Permeability
Ischemia
Immunohistochemistry

Keywords

  • Advanced glycation end product
  • Antioxidant
  • Calcium dobesilate
  • Diabetic retinopathy
  • Vascular permeability
  • VEGF (vascular endothelial cell growth factor)

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. / Rota, Rossella; Chiavaroli, Carlo; Garay, Ricardo P.; Hannaert, Patrick.

In: European Journal of Pharmacology, Vol. 495, No. 2-3, 14.07.2004, p. 217-224.

Research output: Contribution to journalArticle

Rota, Rossella ; Chiavaroli, Carlo ; Garay, Ricardo P. ; Hannaert, Patrick. / Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. In: European Journal of Pharmacology. 2004 ; Vol. 495, No. 2-3. pp. 217-224.
@article{18bf335919b44cd283eb0661502200ed,
title = "Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats",
abstract = "Calcium dobesilate stabilizes blood-retinal barrier in patients with diabetic retinopathy and possesses antioxidant properties in the retinas of rats with streptozotocin-induced diabetes, exposed ex vivo to ischemia-reperfusion. Here we investigated the action of calcium dobesilate on retinal albumin leakage in streptozotocin-diabetic rats, together with relevant in vivo retinal antioxidant and permeability markers, i.e., carboxymethyl-lysine-advanced glycation end product (CML-AGE) formation and vascular endothelial cell growth factor (VEGF) overexpression. Twenty days after streptozotocin administration, diabetic rats were treated for 10 days with calcium dobesilate (100 mg/kg/day per os) or vehicle. Retinal albumin leakage, CML-AGE formation, and VEGF overexpression were evaluated by immunohistochemistry of frozen eye sections. Diabetic rats exhibited dramatic increases in: (i) retinal albumin leakage (31{\%} of positive vessels vs. 0.2{\%} in nondiabetic rats, P-4). Calcium dobesilate significantly reduced: (i) retinal albumin leakage (by 70{\%}, P",
keywords = "Advanced glycation end product, Antioxidant, Calcium dobesilate, Diabetic retinopathy, Vascular permeability, VEGF (vascular endothelial cell growth factor)",
author = "Rossella Rota and Carlo Chiavaroli and Garay, {Ricardo P.} and Patrick Hannaert",
year = "2004",
month = "7",
day = "14",
doi = "10.1016/j.ejphar.2004.05.019",
language = "English",
volume = "495",
pages = "217--224",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats

AU - Rota, Rossella

AU - Chiavaroli, Carlo

AU - Garay, Ricardo P.

AU - Hannaert, Patrick

PY - 2004/7/14

Y1 - 2004/7/14

N2 - Calcium dobesilate stabilizes blood-retinal barrier in patients with diabetic retinopathy and possesses antioxidant properties in the retinas of rats with streptozotocin-induced diabetes, exposed ex vivo to ischemia-reperfusion. Here we investigated the action of calcium dobesilate on retinal albumin leakage in streptozotocin-diabetic rats, together with relevant in vivo retinal antioxidant and permeability markers, i.e., carboxymethyl-lysine-advanced glycation end product (CML-AGE) formation and vascular endothelial cell growth factor (VEGF) overexpression. Twenty days after streptozotocin administration, diabetic rats were treated for 10 days with calcium dobesilate (100 mg/kg/day per os) or vehicle. Retinal albumin leakage, CML-AGE formation, and VEGF overexpression were evaluated by immunohistochemistry of frozen eye sections. Diabetic rats exhibited dramatic increases in: (i) retinal albumin leakage (31% of positive vessels vs. 0.2% in nondiabetic rats, P-4). Calcium dobesilate significantly reduced: (i) retinal albumin leakage (by 70%, P

AB - Calcium dobesilate stabilizes blood-retinal barrier in patients with diabetic retinopathy and possesses antioxidant properties in the retinas of rats with streptozotocin-induced diabetes, exposed ex vivo to ischemia-reperfusion. Here we investigated the action of calcium dobesilate on retinal albumin leakage in streptozotocin-diabetic rats, together with relevant in vivo retinal antioxidant and permeability markers, i.e., carboxymethyl-lysine-advanced glycation end product (CML-AGE) formation and vascular endothelial cell growth factor (VEGF) overexpression. Twenty days after streptozotocin administration, diabetic rats were treated for 10 days with calcium dobesilate (100 mg/kg/day per os) or vehicle. Retinal albumin leakage, CML-AGE formation, and VEGF overexpression were evaluated by immunohistochemistry of frozen eye sections. Diabetic rats exhibited dramatic increases in: (i) retinal albumin leakage (31% of positive vessels vs. 0.2% in nondiabetic rats, P-4). Calcium dobesilate significantly reduced: (i) retinal albumin leakage (by 70%, P

KW - Advanced glycation end product

KW - Antioxidant

KW - Calcium dobesilate

KW - Diabetic retinopathy

KW - Vascular permeability

KW - VEGF (vascular endothelial cell growth factor)

UR - http://www.scopus.com/inward/record.url?scp=3042798298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042798298&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2004.05.019

DO - 10.1016/j.ejphar.2004.05.019

M3 - Article

VL - 495

SP - 217

EP - 224

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -